Increasingly medical technology costs are being challenged by national and private insurers seeking to control costs and maximize healthcare benefits with fixed budgets. As a means of controling healthcare costs, paying bodies regularly question the ‘value for money’ of new and existing medical technologies. This frequently results in delays to launching new products and in some cases products never making it to market.
To address these hurdles and ensure product reimbursement, medical technology companies must address the needs of payers early in product development and over the product lifecycle with the aim of achieving and maintaining prices, and minimizing access and volume restrictions.
GMA Solutions is experienced in working with some of the most difficult international reimbursement systems and is well positioned to design strategies to communicate product value to national and private payers.
| 
